1. Cont’d/
8 June 2015
Intelligent Fingerprinting appoints Philip Hand to spearhead the
launch of its biometric drug screening technology
Philip Hand, a drug industry veteran with more than 20 years’ experience in medical
diagnostics, has been appointed Chairman at Intelligent Fingerprinting, the British company
developing the world’s first fingerprint-based drug screening device. Mr Hand was previously
a non-executive director at the company.
Philip Hand is known for his success in bringing diagnostic screening products to market. He
co-founded the medical diagnostics company Cozart Bioscience Limited which pioneered the
development and manufacture of oral fluid (saliva) testing for drug screening. Following the
company’s AIM listing in 2004 he was its Chief Operating Officer until October 2007 when he
was involved in the negotiation to sell the company to Concateno plc (now Alere Toxicology)
for £65 million.
John Polden, who has been the company’s Chairman since 2009, will remain on the Board
as a non-executive director following Mr Hand’s appointment.
Dr Jerry Walker, Chief Executive Officer, Intelligent Fingerprinting said: “The Board would
like to thank John Polden for his excellent guidance and encouragement as Chairman over
the past six years, during which time we have raised almost £6m in funding and won nearly
£1m in grants and similar awards. John has demonstrated that he is an expert in guiding
start-ups onto the road to future success. He was instrumental in securing all of the early
stage funding for the company and his support has helped us bring an innovative concept to
the point where we can now commercialise our revolutionary biometric drug screening
technology, protected by a broad portfolio of intellectual property covering fingerprint-based
diagnostics.”
Dr Walker continued: “Philip is a seasoned and highly successful business leader. His in-
depth knowledge of the drug screening industry and his experience of bringing diagnostic
screening products to market mean that he is ideally positioned as Chairman to lead the
Press Release

2. Page 2 of 2
company into the most exciting stage in its development – the launch and commercialisation
phase of our ground-breaking technology.”
Mr Hand is a Business Ambassador for the Meningitis Now charity, a Fellow of the Chartered
Institute of Management Accountants and a keen and active sportsman.
-ends-
For media information contact Lorraine Walters at Say Communications
Email: lwalters@saycomms.co.uk Tel: +44 (0)20 8971 6400
Notes to Editors:
About Intelligent Fingerprinting
Intelligent Fingerprinting is developing a revolutionary fingerprint-based portable drug testing device.
The technology, which works by analysing the sweat from a fingerprint sample, will enable non-
invasive, cost-effective screening for multiple drug groups in less than 10 minutes. The product is the
first of its kind in the world and is expected to go into production in 2015.
The company’s ground-breaking technology detects drug use by analysing chemicals, known as
metabolites, contained in the minute traces of sweat found in a fingerprint. (Metabolites are chemicals
produced by the body as a result of normal metabolic processes.) The device looks for the presence
of drug metabolites in the test subject’s fingerprint sweat sample and, if detected, identifies the type of
drugs which have been ingested, inhaled or injected.
A version of the device will allow the capture of a detailed image of the test subject’s fingerprint. This
image may be used to confirm personal identity in relation to the test result, ruling out false positives
due to sample mix ups.
Intelligent Fingerprinting has attracted worldwide interest in its technology from a wide range of drug-
screening markets including the criminal justice arena, drug rehabilitation centres, prisons and
occupational health services. The technique has potential for many other uses including healthcare
diagnostics and homeland security applications.
Since 2012 Intelligent Fingerprinting has raised £5.75m in funding from a consortium of private UK
and US-based investors, as well as government funding for pilot studies within the UK’s National
Health Service and forensics services.
Founded in 2007, Intelligent Fingerprinting is a spin-out company from the University of East Anglia
(UEA). The company is based in Norwich, England and employs 19 people.
www.intelligentfingerprinting.com